InGen Intelligence and Yituo Medicine deepen strategic cooperation.

According to British Silicon Intelligence, British Silicon Intelligence has signed an agreement to expand strategic cooperation with Wuxi Yituo Medical Technology Co., Ltd. On the basis of the phased delivery of small-molecule candidate drugs for tumor target protein degradation research and development cooperation, the two parties will further expand cooperation in adapting indications and focus on AI-empowered skin management and anti-aging in the field of skin innovation drug development. Relying on AI-driven biological platforms and LLPS featured research and development platforms, this will promote the original small-molecule drugs for scientific skin care and anti-aging from basic research to accelerated clinical application and industrial implementation.